Patient Rating:

4.3 out of 5

71 Patient Ratings
30 Patient Comments

Josef T. Prchal, M.D.

Patient Rating:

4.3 out of 5

71 Patient Ratings
30 Patient Comments

Specialties

Languages

  • Czech
  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-6906 Huntsman Cancer Hospital
Myeloproliferative Disorders Clinic
1950 Circle of Hope
Salt Lake City, UT 84112
Map
(801) 582-1565 Veterans Administration Medical Center
Myeloproliferative Disorders Clinic
500 S Foothill Blvd
Salt Lake City, UT 84149

Specialties

Bio

Josef Prchal, MD is a Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah. He is also named Huntsman Cancer Institute Investigator, and is a member of the Cell Response and Regulation Program and the Imaging, Diagnostics, and Therapeutics Program. In addition, he holds adjunct Professor appointments in Human Genetics and in Pathology. At his clinics at Huntsman Cancer Institute's Clinic 2B and at the George E. Wahlen Veteran's Medical Center, he sees benign red cell disorders and Philadelphia chromosome-negative myeloproliferative neoplasms.

For questions regarding Dr. Prchal's practice, our clinical programs or for help identifying the right Hematology specialist for you or for your family member, please feel free to contact our Clinical Care Specialist/New Patient Coordinator at http://www.huntsmancancer.org or (801) 587-4630.

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor
Human Genetics - Adjunct Professor
Pathology - Adjunct Professor
Academic Divisions Hematology/BMT
Board Certification American Board of Internal Medicine (Internal Medicine)
Royal College of Physicians and Surgeons of Canada
Royal College of Surgeons of Canada
Cancer Center Programs Nuclear Control of Cell Growth & Differentiation
Experimental Therapeutics

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.3
My confidence in care provider
4.4
Time care provider spent with me
4.1
Care provider spoke using clear language
4.2
Care provider's effort to include me in decisions
4.3
Care provider's concern for questions & worries
4.3
Care provider's explanation of condition/problem
4.4
Wait time at clinic
2.8
Care provider's friendliness and courtesy
4.4

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

September 29, 2014

Dr. Prchal is outright amazing. He's very cheery, helpful and knowledgeable. He takes time to explain things, and i love that he talks to my mom instead of me (no, it's totally okay!) because it makes my mom feel much better about the situation. He's truly outstanding!

September 22, 2014

We were cared for by several providers. The nursing assistant, the hematology fellow, the nurse practitioner for a bone marrow biopsy, the infusion clinic staff. Almost all were great. Dr. Prchal was not as engaging but was informative. The fellow was engaging and informative. We did not get any end of appointment direction which damped an otherewise fantastic experience.

September 12, 2014

Dr. Prchal is very knowledgeable and I really appreciate his knowledge. He is pretty good at explaining things to me, and I understand his English better now. He does seem to always be in such a rush and I have to ask my questions quickly before he leaves the room.

July 15, 2014

Very helpful doctor who cared about helping me.

June 21, 2014

Again the Dr. saw my father for 3 minutes!

May 22, 2014

Dr. Prchal always makes sure I understand what he tells me--I appreciate this.

February 18, 2014

The doctor told me symptoms to watch for so fast I couldn't write them down. I would have appreciated a printed list of the symptoms to watch for.

February 13, 2014

the care provider did not address any of my concerns. they where more concerned about what they thought. not my concerns

February 12, 2014

I had a good explanation to my questions about my spleen measurements and followup visits.

January 17, 2014

Dr. Prchal seemed annoyed at our questions and concerns. He was short with us and our perception is he just wanted to move on to the next patient.

January 02, 2014

Dr. Prchal is always very personable and informative and concerned about his patient. We are very pleased to have him for a care provider.

November 14, 2013

dr. Prchal seemed very anxious to have me return to work force I don't think he is aware of my fatigue and pain and neurapothy that prevent me from performing prior occupation I am going back to school next year

September 20, 2013

Dr. Prchal and others were great.

July 26, 2013

Dr. Phrcal has made my whole experience much more tolerable and easy. I trust his word- he's a reputable doctor who *really* knows the subject. I'm very happy to have him as my doctor at Huntsman.

June 21, 2013

Dr. Prchal was very thorough and responded to everything I asked him. I had a difficult time hearing him partly because of his accent and partly because my hearing is getting harder to hear. I would've liked perhaps a few more minutes, but I didn't feel neglected in any way.

May 27, 2013

Very pleased with both physicians.

April 19, 2013

he talked fast but seemed very knowledgeable and friendly-with his accent and a mask on I had a hard time following what he was saying but felt I got clarification from the nurse

November 21, 2012

there were no instructions about follow up care

October 30, 2012

I would recommend Dr. Prchal to anyone who needed a hematologist. He is one of the best doctors at Huntsman.

October 17, 2012

unable to find orders for lab work at Redstone clinic the following week without sending several emails and making several phone calls

October 12, 2012

My care from Dr. Nutall (fellow) and Dr. Prchal was outstanding. They did an excellent job in providing my care and including me on a plan for treatment and further workup.

October 04, 2012

The experience was fine the only thing I didn't understand is why I was taken off both chemos and put on interferon I feel worse now than I did when I was on the chemos. It was not explained to me what the objectective was changing treatment.

June 08, 2012

I felt like the doctor and resident were talking so fast that I still have no idea what is going on but I guess I will find out at my next appointment.

June 04, 2012

Appointment felt rushed

March 27, 2012

As mentioned before outstanding provider with extensive experience, very erudite and very patient-focused

March 13, 2012

The doctor saved my life

March 03, 2012

Wish we could mark excellent. Thank you so much.

February 07, 2012

research related visit that did not require treatment or medication, above items not really applicable to visit.

January 10, 2012

Very kind and seemed to be conserned out the problem and took the time to get to know a little about us and not just do this and good bye. Very kind and friendly man

January 05, 2012

I have had nothing but the best the HCI is the Lexus of care facilities and has set a bench mark

Academic Profile

Research Interests

  • Polycythemia
  • Erythorcyte Disorders
  • Hematopoiesis

Board Certification and Academic Information

Academic Departments Internal Medicine - Professor
Human Genetics - Adjunct Professor
Pathology - Adjunct Professor
Academic Divisions Hematology/BMT
Board Certification American Board of Internal Medicine (Internal Medicine)
Royal College of Physicians and Surgeons of Canada
Royal College of Surgeons of Canada
Cancer Center Programs Nuclear Control of Cell Growth & Differentiation
Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-3229 School of Medicine
Hematology/BMT Program
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Josef Prchal, MD is a Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah. He is also named Huntsman Cancer Institute Investigator, and is a member of the Cell Response and Regulation Program and the Experimental Therapeutics Program. In addition, he holds adjunct Professor appointments in Human Genetics and in Pathology. At his clinics at Huntsman Cancer Institute's Clinic 2B and at the George E. Wahlen Veteran's Medical Center, he sees benign red cell disorders and Philadelphia chromosome-negative myeloproliferative neoplasms.

Dr. Prchal's research focuses on defining a molecular basis for congenital and acquired hematological disorders and translational research in myeloproliferative disorders, which are cancerous disorders of the bone marrow. His interest is in discovering the molecular basis of congenital and acquired hematological disorders. As such, he has identified a number of mutations responsible for several polycythemic disorders.

After attending Charles University Medical School in Prague, Dr. Prchal completed his residency in Internal Medicine and a Fellowship in Hematology at the University of Toronto, Canada. He has specialized training in genetics, working with Ernest Beutler at the City of Hope as well as at the University of California, San Francisco and Howard Hughes Institute in the laboratory of Y.W. Kan.

Before joining the University of Utah, Prchal was a professor in the Department of Hematology at the University of Alabama at Birmingham, senior scientist at the University of Alabama Cancer Center, and professor and senior scientist at Baylor College of Medicine in Houston. He serves as Director of the University of Utah's Philadelphia Chromosome Negative Myeloproliferative Disorder Program, which focuses on the study of rare forms of leukemia. He is a founding member of the NCI-funded Myeloproliferative Disorders Consortium, serves on the editorial board of the journal Blood, authors multiple Up-to-date chapters, and is an editor of Williams Hematology and Williams Hematology Manual, most recently their 8th Editions. He has authored 289 peer-reviewed research papers and written 106 editorials, review articles and book chapters.

Prchal was a recipient of the American Cancer Society's Scholar Award.

Education

Education History

Type School Degree
Residency University of Toronto, Department of Medicine
Pathology
Resident
Fellowship University of Toronto, Department of Medicine
Laboratory and Clinical Hematology
Fellow
Fellowship University of Toronto, Department of Medicine
Hematology/Oncology
Fellow
Research Fellow City of Hope National Medical Center
Research
Research Fellow
Residency University of Toronto, Dept of Medicine
Internal Medicine
Resident
Internship University of Toronto, Dept of Medicine
Rotating Internship
Intern
Professional Medical Charles University
M.D.

Publications

Selected Provider Publications

Journal Article

  1. Zhang X, Zhang W, Ma SF, Miasniakova G, Sergueeva A, Ammosova T, Xu M, Nekhai S, Nourai M, Wade MS, Prchal JT, Garcia JG, Machado RF, Gordeuk VR (2014). Iron deficiency modifies gene expression variation induced by augmented hypoxia sensing. Blood Cells Mol Dis, 52(1), 35-45.
  2. Ye Z, Liu CF, Lanikova L, Dowey SN, He C, Huang X, Brodsky RA, Spivak JL, Prchal JT, Cheng L (2014). Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells. Stem Cells, 32(1), 269-78.
  3. Reading NS, Sirdah MM, Tarazi IS, Prchal JT (2014). Detection of nine Mediterranean beta-thalassemia mutations in Palestinians using three restriction enzyme digest panels: a reliable method for developing countries. Hemoglobin, 38(1), 39-43.
  4. Christensen RD, Nussenzveig RH, Reading NS, Agarwal AM, Prchal JT, Yaish HM (2014). Variations in both alpha-spectrin (SPTA1) and beta-spectrin ( SPTB ) in a neonate with prolonged jaundice in a family where nine individuals had hereditary elliptocytosis. Neonatology, 105(1), 1-4.
  5. Kapralova K, Lanikova L, Lorenzo F, Song J, Horvathova M, Divoky V, Prchal JT (2014). RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling. Blood, 123(3), 391-4.
  6. Dickinson RE, Milne P, Jardine L, Zandi S, Swierczek SI, McGovern N, Cookson S, Ferozepurwalla Z, Langridge A, Pagan S, Gennery A, Heiskanen-Kosma T, Hamalainen S, Seppanen M, Helbert M, Tholouli E, Gambineri E, Reykdal S, Gottfreethsson M, Thaventhiran JE, Morris E, Hirschfield G, Richter AG, Jolles S, Bacon CM, Hambleton S, Haniffa M, Bryceson Y, Allen C, Prchal JT, Dick JE, Bigley V, Collin M (2014). The evolution of cellular deficiency in GATA2 mutation. Blood, 123(6), 863-74.
  7. Zhang X, Zhang W, Ma SF, Desai AA, Saraf S, Miasniakova G, Sergueeva A, Ammosova T, Xu M, Nekhai S, Abbasi T, Casanova NG, Steinberg MH, Baldwin CT, Sebastiani P, Prchal JT, Kittles R, Garcia JG, Machado RF, Gordeuk VR (2014). Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease. Circulation, 129(16), 1650-8.
  8. Tashi T, Feng T, Koul P, Amaru R, Hussey D, Lorenzo FR, RiLi G, Prchal JT (2014). High altitude genetic adaptation in Tibetans: no role of increased hemoglobin-oxygen affinity. Blood Cells Mol Dis, 53(1-2), 27-9.
  9. Sarangi S, Lanikova L, Kapralova K, Acharya S, Swierczek S, Lipton JM, Wolfe L, Prchal JT (2014). The homozygous VHL missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension.LID - 10.1002/pbc.25056 [doi]. Pediatr Blood Cancer.
  10. Sangle N, Cook J, Perkins S, Teman CJ, Bahler D, Hickman K, Wilson A, Prchal J, Salama ME (2014). Myelofibrotic Transformations of Polycythemia Vera and Essential Thrombocythemia are Morphologically, Biologically, and Prognostically Indistinguishable From Primary Myelofibrosis. Appl Immunohistochem Mol Morphol.
  11. Rondelli DAUID- ORCID httporcidorg0000-0001-5243-401X, Goldberg JDAUID- ORCID httporcidorg0000-0003-3758-6976, Isola L, Price LS, Shore TB, Boyer MAUID- ORCID httporcidorg0000-0002-0452-2987, Bacigalupo A, Rambaldi A, Scarano M, Klisovic RB, Gupta V, Andreasson B, Mascarenhas JAUID- ORCID httporcidorg0000-0002-8400-0483, Wetzler M, Vannucchi AM, Prchal JT, Najfeld V, Orazi A, Weinberg RS, Miller C, Barosi G, Silverman LR, Prosperini G, Marchioli R, Hoffman R (2014). MPD-RC 101 prospective study of reduced intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.LID - blood-2014-04-572545 [pii]. Blood.
  12. Lorenzo FR, Huff C, Myllymaki M, Olenchock B, Swierczek S, Tashi T, Gordeuk V, Wuren T, Ri-Li G, McClain DA, Khan TM, Koul PA, Guchhait P, Salama ME, Xing J, Semenza GL, Liberzon E, Wilson A, Simonson TS, Jorde LB, Kaelin WG Jr, Koivunen P, Prchal JT (2014). A genetic mechanism for Tibetan high-altitude adaptation. Nat Genet, 46(9), 951-6.
  13. Nussenzveig RH, Christensen RD, Prchal JT, Yaish HM, Agarwal AM (2014). Novel alpha-Spectrin Mutation in Trans with alpha-Spectrin Causing Severe Neonatal Jaundice from Hereditary Spherocytosis. Neonatology, 106(4), 355-357.

Case Report

  1. Boonyawat B, Dhanraj S, Al Abbas F, Zlateska B, Grunenbaum E, Roifman CM, Steele L, Meyn S, Blanchette V, Scherer SW, Swierczek S, Prchal J, Zhu Q, Torgerson TR, Ochs HD, Dror Y (2013). Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. J Clin Immunol, 33(7), 1150-5.
  2. Christensen RD, Yaish HM, Wiedmeier SE, Reading NS, Pysher TJ, Palmer CA, Prchal JT (2013). Neonatal death suspected to be from sepsis was found to be kernicterus with G6PD deficiency. Pediatrics, 132(6), e1694-8.

Editorial

  1. Mascarenhas J, Mesa R, Prchal J, Hoffman R (2014). Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials. Haematologica, 99(6), 945-9.

Letter

  1. Wang L, Swierczek SI, Drummond JAUID- ORCID 0000000226125958, Hickman K, Kim SJ, Walker K, Doddapaneni H, Muzny DM, Gibbs RA, Wheeler DA, Prchal JT (2014). Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes [Letter to the editor]. Leukemia, 28(4), 935-8.
  2. Wang L, Swierczek SI, Lanikova L, Kim SJ, Hickman K, Walker K, Wang K, Drummond JAUID- ORCID 0000000226125958, Doddapaneni H, Reid JG, Muzny DM, Gibbs RA, Wheeler DA, Prchal JT (2014). The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera [Letter to the editor]. Leukemia, 28(4), 938-41.
  3. Salama ME, Swierczek SI, Tashi T, Warby CA, Reading NS, Prchal JT (2014). Calreticulin mutated prefibrotic-stage myelofibrosis and PMF represent an independent clone from coexisting CLL [Letter to the editor]. Blood, 124(10), 1691-2.

Clinical Trials

Clinical Trials

Video & News